Abstract

We studied patterns of off-target receptor interactions, mostly at G protein-coupled receptors (GPCRs) in the µM range, of nucleoside derivatives that are highly engineered for nM interaction with adenosine receptors (ARs). Because of the considerable interest of using AR ligands for treating diseases of the CNS, we used the Psychoactive Drug Screening Program (PDSP) for probing promiscuity of these adenosine/adenine congeners at 41 diverse receptors, channels and a transporter. The step-wise truncation of rigidified, trisubstituted (at N6, C2, and 5′ positions) nucleosides revealed unanticipated interactions mainly with biogenic amine receptors, such as adrenergic receptors and serotonergic receptors, with affinities as high as 61 nM. The unmasking of consistent sets of structure activity relationship (SAR) at novel sites suggested similarities between receptor families in molecular recognition. Extensive molecular modeling of the GPCRs affected suggested binding modes of the ligands that supported the patterns of SAR at individual receptors. In some cases, the ligand docking mode closely resembled AR binding and in other cases the ligand assumed different orientations. The recognition patterns for different GPCRs were clustered according to which substituent groups were tolerated and explained in light of the complementarity with the receptor binding site. Thus, some likely off-target interactions, a concern for secondary drug effects, can be predicted for analogues of this set of substructures, aiding the design of additional structural analogues that either eliminate or accentuate certain off-target activities. Moreover, similar analyses could be performed for unrelated structural families for other GPCRs.

Highlights

  • The potential liabilities and advantages of off-target effects of known drugs have been a growing concern in drug development [1]

  • This was desired to restrict the range of conformations possible, which would aid in conformational analysis and in docking to protein targets

  • We systematically examined the promiscuity of a set of adenosine/adenine congeners to detect unanticipated interactions of these rigidified and highly substituted nucleosides and their substructures with numerous offtarget sites, such as biogenic amine receptors

Read more

Summary

Introduction

The potential liabilities and advantages of off-target effects of known drugs have been a growing concern in drug development [1]. There is interest in understanding the factors affecting drug promiscuity in order to avoid those liabilities early in the drug discovery process. Off-target effects can serve as leads for repurposing of known biologically active scaffolds at new molecular targets. This approach was carried out in the past empirically (for example, using privileged scaffolds such as 1,4-dihydropyridines [5]) and can be performed in a more systematic way with detailed knowledge of the 3D structures of many drug targets including G protein-coupled receptors (GPCRs) [6]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call